Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma

  • Authors:
    • Kai Chen
    • Zhonghu Li
    • Peng Jiang
    • Xi Zhang
    • Yujun Zhang
    • Yan Jiang
    • Yu He
    • Xiaowu Li
  • View Affiliations

  • Published online on: June 11, 2014     https://doi.org/10.3892/or.2014.3245
  • Pages: 755-763
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The metastasis-related molecules CD133, CD44v6 and human tissue factor (TF) have been shown to be associated with tumor invasion and metastasis. This study aimed to determine whether co-expression of these three molecules was associated with metastasis and overall prognosis in pancreatic carcinoma. We analyzed the expression profiles of these three molecules by immunohistochemistry and evaluated the relationship of their expression profiles with metastasis and prognosis in 109 pancreatic carcinomas. The results showed that the expression levels of CD133, CD44v6 and TF were increased in pancreatic carcinoma. Co-expression of CD133, CD44v6 and TF (tri-expression) was also detected in pancreatic carcinoma. Clinical analysis showed that individual expression of CD133, CD44v6 or TF was associated with vessel invasion, lymph node metastasis and liver metastasis, while tri-expression was associated with lymph node metastasis. Survival analysis showed that patients with co-expression of CD133 and TF or tri-expression had lower and the lowest overall survival rates, respectively. Univariate analysis showed that T-factor, lymph node metastasis, TNM stage, and individual levels or tri-expression of CD133, CD44v6 and TF were survival risk factors. Multivariate analysis showed that tri-expression of CD133, CD44v6 and TF was an independent predictor of survival. These results suggest that overexpression of CD133, CD44v6 and TF is associated with pancreatic carcinoma metastasis. Tri-expression of these three molecules may be a useful predictor for pancreatic carcinoma prognosis.
View Figures
View References

Related Articles

Journal Cover

August-2014
Volume 32 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen K, Li Z, Jiang P, Zhang X, Zhang Y, Jiang Y, He Y and Li X: Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma. Oncol Rep 32: 755-763, 2014
APA
Chen, K., Li, Z., Jiang, P., Zhang, X., Zhang, Y., Jiang, Y. ... Li, X. (2014). Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma. Oncology Reports, 32, 755-763. https://doi.org/10.3892/or.2014.3245
MLA
Chen, K., Li, Z., Jiang, P., Zhang, X., Zhang, Y., Jiang, Y., He, Y., Li, X."Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma". Oncology Reports 32.2 (2014): 755-763.
Chicago
Chen, K., Li, Z., Jiang, P., Zhang, X., Zhang, Y., Jiang, Y., He, Y., Li, X."Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma". Oncology Reports 32, no. 2 (2014): 755-763. https://doi.org/10.3892/or.2014.3245